Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the 30th Annual Cowen & Company Health Care Conference at the Boston Marriott Copley Place on Wednesday, March 10, 2010 at 11:00 a.m. Eastern Time.

A live webcast of the presentation will be available on the “Presentations” page of the “Investors” section of Celldex’s website at http://www.celldextherapeutics.com and will be archived for 30 days following the event.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.